A Comparative Efficacy of Low-Dose Combined Oral Contraceptives Containing Desogestrel and Drospirenone in Premenstrual Symptoms

Table 6

The comparison of the prevalence of adverse effects (episodes per 100 samples) between both groups.

Adverse events (AEs)	Prevalence of events (%)		Between-group 𝑃 value
	DSG*	DRSP*
Nausea/vomiting	8 (17.8)	1 (2.2)	NS
Dizziness	1 (2.2)	4 (8.9)	NS
Amenorrhea	3 (6.7)	1 (2.2)	NS
Spotting	2 (4.4)	2 (4.4)	NS
Mastalgia	1 (2.2)	0 (0)	NS

 *DSG: desogestrel group and DRSP: drospirenone group.